Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 350

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Use of designer recombinant mitochondrial antigens in the diagnosis of primary biliary cirrhosis

Open access
Leung, Patrick S. C., Iwayama, Takashi, Prindiville, Thomas, Chuang, David T., Ansari, Aftab A., Wynn, Max R., Dickson, Rollie, Coppel, Ross, Gershwin, Eric M.·1992·Hepatology

Abstract

The appearance of autoantibodies against mitochondria in patients with primary biliary cirrhosis has been known for more than 25 yr. In the past, based on the biochemical complexity of the mitochondrion and the use of crude extracts for immunodiagnosis, a degree of nonspecificity in assaying for antibodies to mitochondria has been present. This problem has been largely circumvented by the cloning of the mitochondrial antigens and the identification of the E2 subunits of the pyruvate dehydrogenase complex and the branched chain 2-oxo-acid dehydrogenase complex as the major and immunodominant autoantigens of primary biliary cirrhosis. More than 90% of patients with primary biliary cirrhosis have been shown to react with one or both of these enzymes using either recombinant antigen or purified native protein. Approximately 10% of patients recognize only E2 subunits of branched chain 2-oxo-acid dehydrogenase complex and not pyruvate dehydrogenase complex. Such patients would be missed by diagnostic assay that has a low sensitivity to antibodies against E2 subunits of branched chain 2-oxo-acid dehydrogenase complex. The use of recombinant and biochemically pure antigens has permitted structural and conformational analysis of epitope mapping. We have taken advantage of the antigenic mapping studies of both primary biliary cirrhosis and branched chain 2-oxo-acid dehydrogenase complex E2 subunits and designed a molecule that expresses the immunodominant epitopes of both. Using this dual-headed molecule that coexpresses the epitope of two different antigens, we report herein a sensitive and reproducible assay for antibodies to mitochondria in patients with primary biliary cirrhosis. We believe that this recombinant protein is the first example of the use of designer molecules for immunodiagnosis. (Hepatology 1992; 15:367-372).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.1840150302

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Cited by

See all 350

Metadata

Authors
Leung, P. S. C., Iwayama, T., Prindiville, T., Chuang, D. T., Ansari, A. A., Wynn, M. R., Dickson, R., Coppel, R., & Gershwin, E. M.
Venue
Hepatology
Published
1992-03
Volume
15
Issue
3
Pages
367-372
ISSN
0270-9139 (ISSN-L)
OpenAlex
W2035804564
Cited by
350
References
26
FWCI
3.61
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Use of designer recombinant mitochondrial antigens in the diagnosis of primary biliary cirrhosis. https://app.cochat.ai/papers/10.1002/hep.1840150302
The paper
Leung, P. S. C., Iwayama, T., Prindiville, T., Chuang, D. T., Ansari, A. A., Wynn, M. R., Dickson, R., Coppel, R., & Gershwin, E. M. (1992). Use of designer recombinant mitochondrial antigens in the diagnosis of primary biliary cirrhosis. Hepatology. https://doi.org/10.1002/hep.1840150302

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.